Browsing: HHS

The Trump administration’s unprecedented $500 million grant for a flu vaccine has confounded experts due to its reliance on outdated technology and early development stage

An analysis of the Department of Health and Human Services’ (HHS) recent decision to rescind the ‘Richardson Waiver’ and its implications for medical technology companies.

Healthcare CFOs need to prepare for potential disruptions to technology, research, and funding tied to HHS workforce cuts proposed by the Trump administration.